Organon & Co
XMUN:7XP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
Organon & Co
XMUN:7XP
|
US |
|
D
|
Dexcom Inc
XMUN:DC4
|
US |
|
I
|
Iniziative Bresciane Inbre SpA
MIL:IB
|
IT |
Wall St Price Targets
7XP Price Targets Summary
Organon & Co
According to Wall Street analysts, the average 1-year price target for 7XP is 9.543 EUR with a low forecast of 7 EUR and a high forecast of 12.734 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 7XP's stock price target?
Price Target
9.543
EUR
According to Wall Street analysts, the average 1-year price target for 7XP is 9.543 EUR with a low forecast of 7 EUR and a high forecast of 12.734 EUR.
What is the Revenue forecast for Organon & Co?
Projected CAGR
0%
Over the last 7 years, the compound annual growth rate for Revenue has been -6%. The projected CAGR for the next 7 years is 0%.
What is the Gross Profit forecast for Organon & Co?
Projected CAGR
2%
Over the last 7 years, the compound annual growth rate for Gross Profit has been -6%. The projected CAGR for the next 7 years is 2%.
What is the Operating Income forecast for Organon & Co?
Projected CAGR
4%
Over the last 7 years, the compound annual growth rate for Operating Income has been -10%. The projected CAGR for the next 7 years is 4%.
What is the Pre-Tax Income forecast for Organon & Co?
Projected CAGR
48%
Over the last 7 years, the compound annual growth rate for Pre-Tax Income has been -23%. The projected CAGR for the next 3 years is 48%.
What is the Net Income forecast for Organon & Co?
Projected CAGR
27%
Over the last 7 years, the compound annual growth rate for Net Income has been -29%. The projected CAGR for the next 7 years is 27%.
